The short version
- The founding 2009 spermidine paper extended lifespan in yeast, flies, worms and human immune cells and reduced oxidative stress in mice, by switching on autophagy through histone deacetylation.
- In 829 Italian adults followed 20 years with repeated diet assessments, all-cause mortality fell from 40.5 to 23.7 deaths per 1,000 person-years across thirds of spermidine intake, a gap the authors likened to being 5.7 years younger.
- The 12-month SmartAge randomised trial of 100 older adults with subjective cognitive decline found no significant effect of spermidine supplementation on memory, with a between-group difference of −0.03 and p = 0.47.
- The trial dose was 0.9mg per day of a wheat germ extract, which the authors noted may have been too low, so the null result argues against the current product rather than against the hypothesis.
- Spermidine supplementation was well tolerated in older adults with no differences from placebo in vital signs, clinical chemistry or haematology.
Spermidine is the most intellectually satisfying molecule in the longevity aisle. It has a plausible mechanism, a named cellular process, a large human cohort behind it and a wheat germ supply chain that makes it cheap to produce. It also has the one thing the category keeps failing to produce, which is a properly powered randomised trial — and that trial is why this article exists.
Where the excitement came from
In 2009, Eisenberg and colleagues reported in Nature Cell Biology that administering spermidine markedly extended the lifespan of yeast, flies, worms and human immune cells, and inhibited oxidative stress in ageing mice. The mechanism was specific rather than hand-waved: in ageing yeast, spermidine triggered epigenetic deacetylation of histone H3 by inhibiting histone acetyltransferases, which upregulated autophagy-related transcripts and switched on autophagy. Deplete endogenous polyamines and you got the opposite — hyperacetylation, reactive oxygen species, early necrotic death, shorter life.
Autophagy is the cell's recycling programme, and "we can pharmacologically switch on recycling" is a genuinely exciting sentence. Note the species list, though. Yeast, flies, worms, cultured human cells. Nothing in that list is a person.
The human epidemiology, which is unusually good
Kiechl and colleagues followed 829 community-dwelling adults aged 45 to 84 in Bruneck, Italy, with diet assessed by repeated dietitian-administered questionnaires across 1995, 2000, 2005 and 2010 — 2,540 separate assessments. Over twenty years, 341 died.
All-cause mortality fell across thirds of increasing spermidine intake from 40.5 to 23.7 deaths per 1,000 person-years. The hazard ratio for all-cause death per one standard deviation of higher intake was 0.74 adjusted for age, sex and caloric ratio, and 0.76 after further adjustment for lifestyle, established mortality predictors and other dietary features. It replicated in an independent Austrian cohort at 0.71.
The authors put the size of it in a way that travels: the gap between the top and bottom third of intake was similar to being 5.7 years younger.
That is a strong observational result. It is also a study of food, not capsules, and people who eat a lot of spermidine are eating wheat germ, legumes, mushrooms and aged cheese — which is to say they have a dietary pattern, and dietary patterns are notoriously hard to disentangle from everything else about the people who follow them.
Then somebody ran the trial
A first pilot looked promising. Wirth and colleagues gave a spermidine-rich wheat germ extract to older adults with subjective cognitive decline for three months and reported moderately enhanced memory performance versus placebo, with a Cohen's d of 0.77 — though the confidence interval on that contrast ran from below zero to 0.35, which the authors were open about by framing the paper around effect sizes rather than significance. A companion safety study in 30 participants at 1.2mg/day found no differences from placebo in vital signs, weight, clinical chemistry or haematology, with compliance above 85%.
So: safe, tolerable, promising pilot. Exactly the point at which the field should run the real thing, and to their credit, they did.
The SmartAge trial randomised 100 participants aged 60 to 90 with subjective cognitive decline to twelve months of a spermidine-rich wheat germ supplement at 0.9mg/day or placebo, double-masked, with mnemonic discrimination as the pre-specified primary outcome.
Over twelve months, no significant change in memory performance — a between-group difference of −0.03, with a confidence interval from −0.11 to 0.05 and a p-value of 0.47. No significant change in the secondary outcomes either. Exploratory analyses hinted at possible effects on verbal memory and inflammation, which the authors correctly labelled as needing validation at a higher dose.
A well-run twelve-month randomised trial with a null primary outcome is worth more than the pilot that preceded it, and it should have changed the marketing. It largely did not.
The dose problem nobody mentions
Look at the numbers again: the trial used 0.9mg per day of an extract, while the Bruneck result came from spermidine spread across a whole varied diet. It is entirely possible that the supplement dose was simply too low to reproduce anything, and the authors say as much. That is a legitimate defence of the hypothesis. It is not a defence of the product currently on sale, which is generally the same wheat germ extract at a similar dose.
What we would actually tell you
We do not sell spermidine. If you want the exposure, food is the version with the cohort data attached — wheat germ, mushrooms, legumes, aged cheese — and it costs less than the capsule.
If you buy the extract, buy it knowing that the best trial run on it found nothing over a year on its primary endpoint, and that the honest hope is a dosing problem rather than a demonstrated effect. That is the same category of hope as taurine, where a rodent result outran the human data, and the same as senolytics, where an excellent mechanism is years ahead of any consumer evidence. Being early is fine. Being sold as though you are late is not.
Good questions
Does spermidine supplementation improve memory?
Not in the best trial run on it. SmartAge randomised 100 older adults with subjective cognitive decline to twelve months of a spermidine-rich wheat germ supplement or placebo and found no significant change in the primary memory outcome or the secondary outcomes. A smaller three-month pilot had suggested a benefit, which is why the larger trial was run.
Is it better to eat spermidine or supplement it?
Food is the version with the human cohort data attached. The Bruneck study measured dietary spermidine, not capsules, and found the mortality gradient across thirds of intake. Wheat germ, mushrooms, legumes and aged cheese are the usual sources. That also gets you fibre and protein, which the extract does not.
Why did the epidemiology look so good if the trial found nothing?
Because people who eat a lot of spermidine eat a particular way, and dietary patterns are hard to separate from everything else about the people who follow them. The Bruneck authors adjusted heavily and the association held, which is impressive but not the same as causation. The randomised trial is the test that outranks it, and it came back flat.
Is spermidine safe to take?
The safety picture is reassuring as far as it goes. A dedicated safety study in 30 older adults at 1.2mg daily found no differences from placebo in vital signs, weight, clinical chemistry or haematology, and the twelve-month trial reported balanced adverse events. What does not exist is multi-year safety data at the higher doses some people now take hoping to beat the null result.
Would a higher dose work better?
Nobody knows, and that is the honest state of it. The trial authors themselves flagged that 0.9mg per day may have been too low and called for higher-dose studies. Until one is run, taking more is an experiment you are funding and conducting on yourself. We would rather say that plainly than let you infer a dose from silence.
Is spermidine worth the money?
On current evidence, no, and we do not sell it so there is nothing behind that answer. A twelve-month randomised trial found nothing on its primary endpoint, and the dietary version of the exposure is cheaper and better supported. If you have a fixed monthly budget for staying capable, training and sleep buy far more of it.
Sources
- Eisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol, 2009. View study
- Kiechl S, Pechlaner R, Willeit P, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr, 2018. View study
- Wirth M, Benson G, Schwarz C, et al. The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial. Cortex, 2018. View study
- Schwarz C, Benson GS, Horn N, et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Netw Open, 2022. View study
- Schwarz C, Stekovic S, Wirth M, et al. Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging (Albany NY), 2018. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
